arrow
P

Percival D. Sampaio-Barros

Universidade de São Paulo
H指数:37
被引数:6,133

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study

重组带状疱疹疫苗在巴西自身免疫性风湿病患者的应用:一项双盲、随机、安慰剂对照、IV期、非劣效性研究

2026-02-090
PRE
Type V Collagen as a Critical Regulator of Fibrillar Matrix Remodeling in a Murine Model of Systemic Sclerosis

V型胶原蛋白作为系统性硬化症小鼠模型中纤维基质重塑的关键调节因子

2025-11-260
OAAI
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering
2024-07-143
PRE
Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis
2024-04-011
OA
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis
2023-10-0611
OA
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
2022-10-036
OAAI
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients
2022-03-012
OA
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
2022-02-0119
OAAI
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases
2021-11-297
OAAI
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
2021-07-30152
OAAI
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
2017-06-011.2K
OAAI